Cincinnati Children’s leads phase 3 trials of CAP-1002, a cell therapy showing promise for late-stage Duchenne muscular dystrophy patients with limited treatment options.
Cincinnati Children’s offers a team-based approach to surgical tone management in cerebral palsy, including SDR and combined rhizotomy techniques.
The epilepsy team at Cincinnati Children’s is expanding its investment in neuromodulation devices as the next treatment frontier for patients with drug-refractory seizures who aren’t surgical candidates.
A Cincinnati Children’s study finds rising anxiety and depression symptoms in youth with headache disorders, despite stable headache severity over 16 years.